Overview of the use of CoQ10 in cardiovascular disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The clinical experience in cardiology with CoQ 10 includes studies on congestive heart failure, ischemic heart disease, hypertensive heart disease, diastolic dysfunction of the left ventricle, and reperfusion injury as it relates to coronary artery bypass graft surgery. The CoQ 10‐lowering effect of HMG‐CoA reductase inhibitors and the potential adverse consequences are of growing concern. Supplemental CoQ 10 alters the natural history of cardiovascular illnesses and has the potential for prevention of cardiovascular disease through the inhibition of LDL cholesterol oxidation and by the maintenance of optimal cellular and mitochondrial function throughout the ravages of time and internal and external stresses. The attainment of higher blood levels of CoQ 10 (>3.5 μg/ml) with the use of higher doses of CoQ 10 appears to enhance both the magnitude and rate of clinical improvement. In this communication, 34 controlled trials and several open‐label and long‐term studies on the clinical effects of CoQ 10 in cardiovascular diseases are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., & Littarru, G. P. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03948.x · Cited by 324
Laaksonen, R., Jokelainen, K., Sahi, T., Tikkanen, M. J., & Himberg, J.-J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90266-x · Cited by 177 · cited 1×
“Human skeletal muscle CoQ10 may actually increase with statin therapy as documented by a Finnish study [33] but human heart muscle tissue CoQ 10 data are presently lacking and, when available, should help clarify the mechanism of clinical deterioration noted in some cardiomyopathy patients treated with statins.”
BackgroundInteractions between ubiquinones and vitamins in membranes and cells
Constantinescu, A., Maguire, J. J., & Packer, L. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90013-2 · Cited by 73 · cited 1×
“CoQ10 is known to be closely linked to vitamin E and serves to regenerate the reduced (active) α-tocopherol form of vitamin E [9].”
Background
Cited by
Metabolism and function of coenzyme Q
Turunen, M., Olsson, J., & Dallner, G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.11.012 · Cited by 1,026
Biochemical Functions of Coenzyme Q 10
Crane, F. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719063 · Cited by 869
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Bhagavan, H. N., & Chopra, R. K. (2006) · Free Radical Research · doi:10.1080/10715760600617843 · Cited by 550
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
Bhagavan, H. N., & Chopra, R. K. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.003 · Cited by 243
“A large number of these studies relate to cardiovascular diseases where CoQ10 has been used as an adjunct to standard medical therapy (Greenberg and Frishman, 1990; Overvad et al., 1999; Langsjoen and Langsjoen, 1999; Belardinelli et al., 2006).”
BackgroundNutraceuticals, Vitamins, Antioxidants, and Minerals in the Prevention and Treatment of Hypertension
HOUSTON, M. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.01.004 · Cited by 209
Kwong, L. K., Kamzalov, S., Rebrin, I., Bayne, A.-C. V., Jana, C. K., Morris, P., Forster, M. J., & Sohal, R. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00916-4 · Cited by 198
“Although numerous clinical studies have reported ameliorative effects of CoQ intake on a variety of human diseases, particularly those associated with the nervous system, heart, and skeletal muscles, the validity of such claims and the nature of the mechanisms by which CoQ provides a beneficial effect remain virtually…”
Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis
Fotino, A. D., Thompson-Paul, A. M., & Bazzano, L. A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.040741 · Cited by 185
“The CoQ10 concentration has been inversely related to the severity of CHF (5), and supplementation with CoQ10 has been postulated to improve CHF (6, 7).”
BackgroundLangsjoen, P. H., & Langsjoen, A. M. (2003) · BioFactors · doi:10.1002/biof.5520180212 · Cited by 112
Self-citationCicero, A. F. G., Grassi, D., Tocci, G., Galletti, F., Borghi, C., & Ferri, C. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0296-6 · Cited by 79
Metadata
- Authors
- Langsjoen, P. H., & Langsjoen, A. M.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 1999-01
- Volume
- 9
- Issue
- 2-4
- Pages
- 273-284
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W1810099991
- Cited by
- 147
- References
- 3
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.